Vertex Pharmaceuticals
VRTX
VRTX
610 hedge funds and large institutions have $36.1B invested in Vertex Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 269 increasing their positions, 181 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
610
Holders Change
+29
Holders Change %
+4.99%
% of All Funds
15.23%
Holding in Top 10
13
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+62.5%
% of All Funds
0.32%
New
80
Increased
269
Reduced
181
Closed
41
Calls
$386M
Puts
$331M
Net Calls
+$54.2M
Net Calls Change
-$193M
Top Buyers
1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$288M |
2 |
Renaissance Technologies
New York
|
+$205M |
3 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$163M |
4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$159M |
5 |
Jennison Associates
New York
|
+$146M |